21 May 2009
Is acute rejection more frequent in kidney recipients of expanded criteria donors?
P Domagała, A Kwiatkowski, A Perkowska-Ptasińska, M Wszoła, K Ostrowski, Ł Panufnik, M Durlik, L Pączek, A ChmuraAnn Transplant 2009; 14(1): 50-50 :: ID: 880381
Abstract
Background: Kidney transplantation is the treatment of choice for patients with the end-stage renal disease. Organ shortage is the main barrier to offering this treatment. Using expanded criteria donor's (ECD) organs is one of the strategies to make more transplants available, but may be associated with
additional acute rejection episodes due to stronger antigens expression. Aim:
The aim of this study was to assess the frequency of acute rejection episodes
in recipients receiving a kidney from expanded criteria donor.
Material/Methods: One hundred and seventy two patients received cadaveric
renal transplant between January 1[sup]st[/sup], 2006 and August 31[sup]st[/sup], 2008. Data on donors and recipients was collected. Patient and graft survival as well as acute rejection episodes were analysed. Acute rejection episodes were identified by noting steroid treatment of acute rejection. The follow-up was completed on November 30[sup]th[/sup], 2008. All patients were followed-up for three to thirty five months.
Results: Average 1-year graft survival was 86.9% for the whole group and the mean creatinine concentration was 1.58 ml/dl. One case of primary non-function was observed (0.6%). More than 25% of transplanted kidneys were harvested from ECD. Recipients of ECD kidneys were more likely to have more episodes of acute rejection (57.1% vs. 21.2%, p=0.005).
Conclusions: Recipients of expanded criteria donor kidneys experience more episodes of acute rejection.
Keywords: Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






